Sweden has strong scores across most categories in the Severe Asthma Index. As one of the top performers in Policy Context, Sweden has the highest level of tobacco control but could have better alignment with international guidelines. Sweden also presents with excellent drug and treatment access and coverage compared to other countries in the Index. Access to biologics is good, with a comparatively low level of unmet need. Compared to other countries, Sweden has a low rate of asthma hospitalisations and the fewest average number of days spent in the hospital, but Sweden presents one of the highest estimated societal costs of severe asthma.
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Sweden
Provides further insights into how Sweden scores across each Index category
Guidelines, strategies, and policies related to the management of severe asthma and health outcomes
Regulations and practices concerning public payor coverage for and availability of diagnostic and treatment services for severe asthma
Indicators related to clinical management and economic impact of severe asthma and recording of patient health data
Information about the health impact of severe asthma and severe asthma comorbidities
Factors impacting prevention, management, and exacerbations of severe asthma
Aggregate score across the 5 categories.
Explore how each of the 29 OECD countries scored in the Severe Asthma Index
Select different countries to see how they scored across each of the 5 categories and overall